Antibody Conjugates-Recent Advances and Future Innovations

Monoclonal antibodies have evolved from research tools to powerful therapeutics in the past 30 years. Clinical success rates of antibodies have exceeded expectations, resulting in heavy investment in biologics discovery and development in addition to traditional small molecules across the industry....

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, Donmienne, Wurst, Jacqueline M., Liu, Tao, Martinez, Ruben M., Datta-Mannan, Amita, Feng, Yiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148502/
https://www.ncbi.nlm.nih.gov/pubmed/31936270
http://dx.doi.org/10.3390/antib9010002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148502/
https://www.ncbi.nlm.nih.gov/pubmed/31936270
http://dx.doi.org/10.3390/antib9010002

Ejemplares similares